✦ LIBER ✦

‘Let’s stick together’ Adherence to disease-modifying therapies in multiple sclerosis

✍ Scribed by T. Berger

Book ID: 111066434
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 59 KB
Volume: 18
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2010.03111.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease modifying therapies in multiple

Disease modifying therapies in multiple sclerosis

✍ B. Sharrack; T. Jenkins 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Emerging Disease-Modifying Therapies in

Emerging Disease-Modifying Therapies in Multiple Sclerosis

✍ Perumal, Jai; Khan, Omar 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 150 KB

Current and future disease-modifying the

Current and future disease-modifying therapies in multiple sclerosis

✍ S. Y. Lim; C. S. Constantinescu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Impact of adherence to disease-modifying

Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis

✍ Hiangkiat Tan; Qian Cai; Sonalee Agarwal; Judith J. Stephenson; Siddhesh Kamat 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 585 KB

The Global Adherence Project (GAP): a mu

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

✍ V. Devonshire; Y. Lapierre; R. Macdonell; C. Ramo-Tello; F. Patti; P. Fontoura; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Impact of Disease-Modifying Therapies on

Impact of Disease-Modifying Therapies on Brain and Spinal Cord Atrophy in Multiple Sclerosis

✍ Richard A. Rudick 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB